Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
Filinvest net income rises 27%

2018-05-16 bworldonline
FILINVEST Development Corp. (FDC) delivered a 27% increase in its net income attributable to the parent for the first quarter of 2018, driven mainly by its property unit and investments in the hospitality and leisure sector.
FILIY FVSMF FDC FLI

5
FDC nets P2.8B

2018-05-16 business.inquirer.net
Gotianun-led conglomerate Filinvest Development Corp. grew first quarter net profit by 18 percent year-on-year to P2.8 billion, mostly driven by its property business.
FILIY FVSMF FDC FLI

8
Widus sees $1-billion expansion in Clark

2018-05-07 bworldonline
KOREAN-LED Widus International Leisure, Inc., the operator of the Marriot hotel chain in Clark, Pampanga, is looking at expanding its hotel projects in the city to total to $1 billion in the next few years.
FILIY FVSMF MWP FDC GMRINFRA GMQRY FLI MWIDE 532754

5
Filinvest Land keeps capex steady in 2018

2018-04-22 bworldonline
FILINVEST LAND, Inc. (FLI) is keeping its capital spending steady in 2018, as the Gotianun-led developer aims for at least high single-digit growth boosted by its office segment.
FILIY FVSMF FDC FLI

6
Filinvest Development nets P10.3 billion

2018-04-10 bworldonline
FILINVEST Development Corp. (FDC) grew its net profit by more than a fifth last year, buoyed by its banking and property businesses.
FILIY FVSMF EW FDC FLI

4
FDC nets P10.3B

2018-04-10 business.inquirer.net
Gotianun-led Filinvest Development Corp. (FDC) boosted net profit last year by 21 percent to P10.3 billion, driven by higher earnings from the banking, property and power generation businesses.
FVSMF FLI

5
Gotianun-led FDC to build $200-M casino in Clark

2018-04-05 bworldonline
THE GOTIANUN FAMILY is the latest group to venture into the booming gaming sector after securing a license to build a casino in Pampanga.
FILIY FVSMF FDC FLI

4
Filinvest breaks ground on San Pedro project

2018-03-23 bworldonline
LISTED company Filinvest Land, Inc. recently broke ground on its a mid-income residential project called Southwind, the newest addition to it’s South Peak community development in San Pedro, Laguna.
FVSMF FLI

5
Rental revenues push FLI profit 9% higher in 2017

2018-03-21 bworldonline
FILINVEST Land, Inc. (FLI) grew its earnings by 9% in 2017, fueled by the expansion of its rental business alongside demand for both retail and office spaces.
FVSMF FLI

4
Filinvest Land grows earnings by 9% in 2017

2018-03-21 bworldonline
Filinvest Land, Inc. (FLI) grew its earnings by 9% in 2017, fueled by the expansion of its rental properties alongside demand from both retail and office spaces.
FVSMF FLI

5
FLI nets P5.83B

2018-03-21 business.inquirer.net
Gotianun-led property developer Filinvest Land Inc. (FLI) grew its net profit last year by 9 percent to P5.83 billion on higher rental revenues from its new office and shopping malls.
FVSMF FLI

4
Filinvest’s 100 West wins Best Investment Property Award

2018-03-12 business.inquirer.net
Filinvest Land Inc. adds another feather to its cap as 100 West, a mixed-use development envisioned to be the go-to place where one can lead a multi-faceted lifestyle, won the prestigious Best Investment Property in this year’s Southeast Asia’s Best of the Best Awards by Dot Property, a digital media company that drives a network of nine property portal websites and offline media throughout Asia in recognition of the absolute best projects, developers and companies that contribute to real estate.
FVSMF FLI

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: Y24916101